| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA562155
Max Phase: Preclinical
Molecular Formula: C15H17NO8
Molecular Weight: 339.30
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COC(=O)C(CC(=O)O)(CC(=O)O)NC(=O)COc1ccccc1
Standard InChI: InChI=1S/C15H17NO8/c1-23-14(22)15(7-12(18)19,8-13(20)21)16-11(17)9-24-10-5-3-2-4-6-10/h2-6H,7-9H2,1H3,(H,16,17)(H,18,19)(H,20,21)
Standard InChI Key: OAPKRAUFMYYLSD-UHFFFAOYSA-N
Associated Targets(non-human)
Beta-lactamase 38 Activities
Imipenem-hydrolyzing beta-lactamase 46 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Beta-lactamase 730 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Beta-lactamase OXA-10 127 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Beta-lactamase VIM-4 18 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 339.30 | Molecular Weight (Monoisotopic): 339.0954 | AlogP: 0.04 | #Rotatable Bonds: 9 |
| Polar Surface Area: 139.23 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.40 | CX Basic pKa: | CX LogP: 0.05 | CX LogD: -6.51 |
| Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.54 | Np Likeness Score: -0.48 |
References
| 1. Beck J, Vercheval L, Bebrone C, Herteg-Fernea A, Lassaux P, Marchand-Brynaert J.. (2009) Discovery of novel lipophilic inhibitors of OXA-10 enzyme (class D beta-lactamase) by screening amino analogs and homologs of citrate and isocitrate., 19 (13): [PMID:19467869] [10.1016/j.bmcl.2009.04.149] |
Source
Source(1):